Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business Vancouver, British Columbia–(Newsfile Corp. – July 31, 2020) – Emerald Health Therapeutics,...
Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis...
Emerald Health Therapeutics Acquires Cannabis Licensed Producer in Québec New Emerald operation, one of only six licensed producers in Québec, adds indoor growing capacity of approximately 10,000 kg per...
Emerald Provides Corporate Update and Lays out 2017 Growth Initiatives VICTORIA, Feb. 22, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) ((“Emerald” or the “Company”) provides...
Emerald Announces Closing of $13.8 Million Bought Deal VICTORIA, Feb. 10, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) is pleased to announce the closing...
Canadian licensed producer Emerald Health (TSXV: EMH) (OTC: TBQBF) announced a bought deal to raise $10mm by selling 7.408mm Units at $1.35 consisting of common shares and a warrant...
Blogger Marc Davis profiled Emerald Health (TSXV: EMH) (OTC: TBQBF) recently, discussing the strategy of its Executive Chairman, Dr. Avtar Dhillon, who is building a business focused on medical...
Emerald Health Launches Cannabis Oil VICTORIA, Sept. 22, 2016 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Therapeutics”) is pleased to announced that its wholly owned subsidiary, Emerald Health...
